Tilray Launches Initial Public Offering

Tilray joins Nasdaq

CANADA: Tilray, a vertically-integrated and federally-licensed cannabis cultivator, processor and distributor, announced that it has launched an initial public offering of its Class 2 common stock pursuant to a registration statement on Form S-1 previously filed with the United States Securities and Exchange Commission. Tilray has applied to list its common stock on the Nasdaq Global Read the full article…

High Park Farms Begins Cannabis Cultivation in Ontario

“British Columbia is known around the world for its rich cannabis culture and the quality of its cannabis genetics”

CANADA: High Park Farms has announced that cannabis cultivation has begun at its state-of-the-art greenhouse in Enniskillen, Ontario following the successful arrival of thousands of live cannabis plants from Nanaimo, British Columbia. The arrival of the plants marks a major milestone for High Park as the company rapidly scales its operations in anticipation of the historic legalization Read the full article…

Tilray Launches High Park Company to Produce And Distribute Adult-Use Cannabis In Canada

High Park Farms in Enniskillen, Ontario

CANADA: In anticipation of the historic legalization of adult-use cannabis in Canada,  Tilray has announced the creation of wholly-owned subsidiary High Park Company to produce and distribute a broad-based portfolio of cannabis brands and products. As a part of this announcement, the company announced it will be making an investment of up to $10 million in a new facility located in Read the full article…

Tilray Signs Letter Of Intent With Pharmasave

Tilray® Signs Letter of Intent with Pharmasave

CANADA:  Tilray Canada announced that it has entered into a Letter of Intent (LOI) to become a preferred medical cannabis supplier to Pharmasave, the premier independent pharmacy banner in Canada. Subject to changes to Canadian regulations that would allow such distribution, Tilray will supply and distribute Good Manufacturing Practices (GMP) certified Tilray-branded medical cannabis products through Pharmasave pharmacists. Read the full article…

Tilray Forms Strategic Alliance With Leading Pharmaceutical Company In Canada

Agreement represents major milestone recognizing medical cannabis as a conventional medicine for patients in need

CANADA: Tilray, a federally licensed producer of medical cannabis, announced today that it has signed a binding letter of intent (LOI) to be the exclusive collaborator of a major pharmaceutical company to accelerate innovation and increase availability of high quality medical cannabis products. Through this LOI and the anticipated definitive agreements, Tilray is allied with Sandoz Read the full article…

Tilray Announces Completion Of Series A Funding Round Led by Global Institutional Investors

Tilray closes Series A Round

C$60 million Series A financing will enable Tilray to increase production capacity and expand distribution in North America and Europe CANADA:  Tilray has announced the completion of its Series A funding round totaling C$60 million. The round was comprised of a group of leading global institutional investors. According to a company press release, Tilray will use Read the full article…

The Goodship Joins Privateer Holdings

The Goodship joins Privateer Holdings

WASHINGTON:  The Goodship, Washington state’s popular and beloved cannabis edibles brand, announced today that it has joined the Privateer Holdings family of brands. Together, The Goodship and Privateer Holdings will develop new products and expand the brand’s availability to consumers in new markets across North America. Founded in 2014 by Jody Hall, The Goodship makes “damn Read the full article…

Tilray Receives License to Produce Medical Cannabis In The European Union

Tilray to build European Union Campus in Portugal

Company Announces €20 Million Investment to Build EU Campus and Begin Operations this Year PORTUGAL: Tilray has announced plans today to invest up to €20 million in a European Union Campus after receiving licenses from the Government of Portugal to import cannabis genetics and to cultivate cannabis for medical purposes. “Tilray’s EU Campus is another strategic Read the full article…

Tilray Announces Medical Cannabis Export To Cyprus

Tilray to export mmj to Cyprus

CANADA:  Tilray, a global leader in medical cannabis research and production, today announced that Tilray cannabinoid products have arrived and are cleared for distribution in European Union member state Cyprus after the company received necessary approvals in Canada and Cyprus to export cannabinoid formulations for patients in Cyprus. “We are proud to be able to offer Read the full article…

Tilray Completes First Bulk Medical Cannabis Export To Australia Under New Regulations

Tilray mmj products are going Down Under

CANADA: Tilray, a global leader in medical cannabis research and production, today announced it has completed its first import of medical cannabis products into Australia under the country’s new import regulations. The products were produced at Tilray’s federally licensed, GMP-certified facility in Canada and can be dispensed to any patient with a valid prescription. “We are Read the full article…